Advertisement
Algorithm distinguishes between benign and malignant masses
Study demonstrates effectiveness of novel technique to improve lymph drainage after axillary lymphadenectomy
Radiogenomic signature could identify patients likely to benefit from targeted therapy
Bioimpedance spectroscopy (BIS) as a BCRL detection tool
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Oncologist leads new Center for Clinical Artificial Intelligence
Our process and results
Hope that effective therapies will soon exist for all tumor profiles
Microsurgery technique may provide relief to patients
Researchers testing innovative design
Research supported by a recent $3.16 million NCI grant
Advertisement
Advertisement